Stay updated with breaking news from Transfer System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Late-Breaking presentation of phase 2 results from a clinical trial of GX-188E in combination with KEYTRUDA(pembrolizumab) demonstrates anti-tumor benefit in heavily pre-treated, recurrent and advanced
Genexine (KOSDAQ: 095700), a publicly traded, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of unmet medical needs, announced
/PRNewswire/ -- Bimini Health Tech ("Bimini" or the "Company"), a diversified medical device and regenerative therapy company, announced today that it will...
Powder handling and process specialist Dec Group will show innovative flow chemistry solutions with recently acquired UK-based Alconbury Watson (AWL)...
Xante Making Traditional Cylinder Printing Obsolete